Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease.
Colao
A
A
Department of Molecular and Clinical Endocrinology, Federico II University of Naples, Italy. colao@unina.it
Pivonello
R
R
Lastoria
S
S
Faggiano
A
A
Ferone
D
D
Lombardi
G
G
Fenzi
G
G
D006111:Graves Disease / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006801:Humans; D007205:Indium Radioisotopes; D015282:Octreotide / Q000031:analogs & derivatives; D004369:Pentetic Acid / Q000031:analogs & derivatives; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin / Q000032:analysis*; D013004:Somatostatin / Q000031:analogs & derivatives; D013725:Terbium
D007205:Indium Radioisotopes; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin; D013725:Terbium; C071632:SDZ 215-811; D013004:Somatostatin; D004369:Pentetic Acid; D015282:Octreotide